| |
Arthritis News Archive09-Aug-2008
Danvers youth to lead 12th annual Boston Arthritis Walk (Danvers Herald)
Kobe Marinko, age 11, of Danvers, has been chosen one of two Ambassadors for the 12 annual Boston arthritis Walk, to be held on Sunday, Sept. 21 at the Prudential Center in Boston.
Researching the power of the placebo effect in arthritis patients (PhysOrg)
(PhysOrg.com) -- People with arthritis are to take part in new research carried out at The University of Manchester to find out more about how the placebo effect works.
Arthritis support group for senior citizens in West Islip (Amityville Record)
An arthritis support group tailored to the needs of senior citizens, sponsored by the Arthritis Foundation, will meet Thurs., Aug. 7, 12:30 to 2 p.m. at the West Islip Senior Citizen Center, 90 Higbie Ln., West Islip. The program is offered free of charge and open to the public. For more information, contact the Arthritis Foundation, Long Island Chapter at 631-427-8272.
Exercise Classes (Northwest Herald)
Exercise Classes Arthritis and just for the health of it chair and more exercise class, 8 to 8:45 a.m. Monday, Wednesday and Friday, McHenry County Senior Services Center, 3519 N. Richmond Road, McHenry. Arthritis Foundation certified. Information: 815-344-3555.
Doctors Seeing More Arthritis In Active Boomers (Local 6 Orlando)
They went to Woodstock, danced to rock and roll and disco music, and now active Baby Boomers are approaching retirement, many of them facing painful arthritis in their toes, feet and ankles.
Juvenile Arthritis Day at Slugger museum (Louisville Courier-Journal)
Saturday is Juvenile Arthritis Day ? an event designed to empower children living with arthritis to take control of their disease. The event will be from 10 a.m. to 3 p.m. at Louisville Slugger Museum & Factory.
Hollis-Eden Pharmaceuticals initiates Phase I/II rheumatoid arthritis trial (Pharmaceutical Business Review)
Hollis-Eden Pharmaceuticals has started a Phase I/II open label dose ranging clinical trial with its investigational oral drug candidate Triolex in patients diagnosed with rheumatoid arthritis and receiving a stable dose of methotrexate, the current standard of care in rheumatoid arthritis.
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|